DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

CHF-6333

Generic Name: CHF-6333

Drug Type: Small Molecule

Chemical Formula: C_₂₈H_₃₁F_₃N_₆O_₆S

CAS Number: 1613621-54-7

Unique Ingredient Identifier: Q0656F336Y

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis

Phase 1

Recruiting

Posted: 2023/12/12

Sponsor:Chiesi Farmaceutici ...

A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Inhalation in Patients With Cystic Fibrosis (CF) and in Patients With Non Cystic Fibrosis (NCFB) Bronchiectasis

Phase 1

Completed

Posted: 2019/07/08

Sponsor:Chiesi Farmaceutici ...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

Non-Cystic Fibrosis Bronchiectasis Market Expected to Reach USD 7.5 Billion by 2035, Driven by Novel Therapies

2 months ago

The Non-Cystic Fibrosis Bronchiectasis (NCFB) market is projected to grow from USD 1.7 billion in 2024 to USD 7.5 billion by 2035, representing a robust CAGR of 14.62%.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy